Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing postoperative drainage after CABG
IRCT20230626058586N1Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of tranexamic acid in coronary arteriosclerosis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative chest drainage output. Started Jul 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20230626058586N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058586N1.